Quantitative Proteomics Reveal an Altered Pattern of Protein Expression in Brain Tissue from Mice Lacking GPR37 and GPR37L1

• Published in: Journal of proteome research Vol. 19; no. 2; pp. 744 - 755
• Main Authors: Nguyen, TrangKimberly Thu, Dammer, Eric B, Owino, Sharon A, Giddens, Michelle M, Madaras, Nora S, Duong, Duc M, Seyfried, Nicholas T, Hall, Randy A
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 07.02.2020
• Subjects: Animals; Brain - metabolism; HEK293 Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Proteomics; Receptors, G-Protein-Coupled - genetics; Receptors, G-Protein-Coupled - metabolism; calcium; secretion; calcium-binding protein; oligodendrocyte; S100A5; glia; astrocyte
• ISSN: 1535-3893; 1535-3907
• DOI: 10.1021/acs.jproteome.9b00622

GPR37 and GPR37L1 are glia-enriched G protein-coupled receptors that have been implicated in several neurological and neurodegenerative diseases. To gain insight into the potential molecular mechanisms by which GPR37 and GPR37L1 regulate cellular physiology, proteomic analyses of whole mouse brain tissue from wild-type (WT) versus GPR37/GPR37L1 double knockout (DKO) mice were performed in order to identify proteins regulated by the absence versus presence of these receptors (data are available via ProteomeXchange with identifier PXD015202). These analyses revealed a number of proteins that were significantly increased or decreased by the absence of GPR37 and GPR37L1. One of the most decreased proteins in the DKO versus WT brain tissue was S100A5, a calcium-binding protein, and the reduction of S100A5 expression in KO brain tissue was validated via Western blot. Coexpression of S100A5 with either GPR37 or GPR37L1 in HEK293T cells did not result in any change in S100A5 expression but did robustly increase secretion of S100A5. To dissect the mechanism by which S100A5 secretion was enhanced, cells coexpressing S100A5 with the receptors were treated with different pharmacological reagents. These studies revealed that calcium is essential for the secretion of S100A5 downstream of GPR37 and GPR37L1 signaling, as treatment with BAPTA–AM, an intracellular Ca2+ chelator, reduced S100A5 secretion from transfected HEK293T cells. Collectively, these findings provide a panoramic view of proteomic changes resulting from loss of GPR37 and GPR37L1 and also impart mechanistic insight into the regulation of S100A5 by these receptors, thereby shedding light on the functions of GPR37 and GPR37L1 in brain tissue.